FdaApplication
BLA 761092
Identifiers
- fda_app_no: BLA761092
Properties
| Property | Value |
|---|---|
| applicant_name | Chiesi USA, Inc. |
| application_type | BLA |
| approval_date | 2018-10-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REVCOVI | ELAPEGADEMASE-LVLR | 2.4MG/1.5ML (1.6MG/ML) | Injection |
1 product